Risk factors for post-transplant lymphoproliferative disorder in pediatric patients: A case-control study

Pediatric Transplantation

Volumn 9, Issue 4, 2005, Pages 450-455

  Allen, Upton D ^a   Farkas, Gabrielle ^b   Hébert, Diane ^a   Weitzman, Sheila ^a   Stephens, Derek ^c   Petric, Martin ^a   Tellier, Raymond ^a   Ngan, Bo ^a   Fecteau, Annie ^a   West, Lori ^a   Wasfy, Samia ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Epstein Barr virus; Lymphoproliferative disorder; Transplantation

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CYCLOSPORIN; GANCICLOVIR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; T LYMPHOCYTE ANTIBODY; TACROLIMUS;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BIOPSY; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOPROLIFERATIVE DISEASE; MALE; ORGAN TRANSPLANTATION; POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; VIRUS LOAD;

ADOLESCENT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; LOGISTIC MODELS; LYMPHOPROLIFERATIVE DISORDERS; MALE; ORGAN TRANSPLANTATION; RISK FACTORS;

EID: 23844523468     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00318.x     Document Type: Article

References (25)

1. HANTO DW, FRIZZERA G, GAJL-PECZALSKA KJ, et al. Epstein-Barr virus (EBV) induced B-cell lymphoma after renal transplantation. N Engl J Med 1982: 306: 913-918.
2. POPE JH, HORNE MK, SCOTT W. Transformation of foetal human leukocytes in vitro by filtrates of a human leukemic cell line containing herpes-like virus. Int J Cancer 1968: 3: 857-866.
3. STARZL TE, NALESNIK MA, PORTER KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984: 1: 583-587.
4. SHAPIRO RS, MCCLAIN K, FRIZZERA G, et al. Epstein-Barr virus-associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988: 71: 1234-1243.
5. NALESNIK MA, JAFFE R, STARZL TE, et al. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988: 133: 173-192.
6. YOUNG L, ALFIERI C, HENNESSY K, et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 1989: 321: 1080-1085.
7. HANTO DW, GAJL-PECZALSKA KJ, FRIZZERA G, et al. Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation: Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg 1983: 198: 356-369.
8. Ho M, MILLER G, ATCHISON RW, et al. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: The role of primary infection. J Infect Dis 1985: 152: 876-878.
9. WALKER RC, MARSHALL WF, STRICKLER JG, et al. Pretransplant assessment of the risk of lymphoproliferative disorder. Clin Infect Dis 1995: 20: 1346-1353.
10. Ho M, JAFFE R, MILLER G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988: 45: 719-727.
11. Cox KL, LAWRENCE-MIYASAKI LS, GARCIA-KENNEDY R, et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 1995: 59: 524-529.
12. NEWELL KA, ALONSO EM, WHITINGHAM PF, et al. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Transplantation 1996: 62: 370-375.
13. GREEN M, MICHAELS MG, WEBBER SA, ROWE D, REYES J. The Management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients. Pediatr Transplant 1999: 3: 271-281.
14. HARRIS NL, FERRY JA, SWERDLOW SH. Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop. Semin Diagn Pathol 1997: 14: 8-14.
15. ALLEN UD, HÉBERT D, TRAN D, et al. Utility of semiquantitative polymerase chain reaction for Epstein-Barr virus among pediatric solid organ transplant recipients with and without post-transplant lymphoproliferative disease. Clin Infect Dis 2001: 33: 145-150.
16. Centers for Disease Control and Prevention. Epi Info, Version 6.04d. Atlanta, Georgia: Centers for Disease Control and Prevention, 2001.
17. SAVOIE A, PERPêTE C, CARPENTIER L, JONCAS J, ALFIERI C. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 1994: 83: 2715-2722.
18. RIDDLER SA, BREINIG MC, MCKNIGHT JLC. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 1994: 84: 972-984.
19. KENAGY DN, SCHLESINGER Y, WESK K, RITTER JH. Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation 1995: 60: 547-554.
20. BUSTAMI RT, OJO AO, WOLFE RA, et al. Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant 2004: 4: 87-93.
21. DHARNIDHARKA VR, TEJANI AH, Hoc P-L, HARMON WE. Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk. Am J Transplant 2002: 2: 993-998.
22. HENLE G, HENLE W, CLIFFORD P, et al. Antibodies to EB virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst 1969: 43: 1147-1157.
23. HENLE G, HENLE W. Observations on childhood infections with the Epstein-Barr virus. Infect Dis 1970: 121: 303-310.
24. HOWARD TK, KLINTMALM GB, STONE MJ. Lymphoproliferative disorder masquerading as rejection in liver transplant recipients - an early aggressive tumor with atypical presentation. Transplantation 1992: 53: 1145-1147.
25. CRAIG FE, GULLEY ML, BANKS PM. Post-transplantation lymphoproliferative disorders. Am J Clin Pathol 1993: 99: 265-276.